Why Genentech will say 'yes' to Roche CNNMoney.com - 3 hours ago As drugs from the first wave of biotech approvals two decades ago are approaching patent expiration, patients, doctors and insurers are demanding ... |
|
Leave a Reply
You must be logged in to post a comment. Login » |

Entries (RSS)